@misc{indiciae6e8b632350e2,
  title = {T cell response following anti COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern},
  author = {Cohen, H. and Rotem, S. and Elia, U. and Bilinsky, G. and Levy, I. and Chitlaru, T. and Bar-Haim, E.},
  year = {2022},
  doi = {10.1101/2022.01.19.476497},
  url = {https://www.biorxiv.org/content/10.1101/2022.01.19.476497v1},
  note = {Source identifier: 10.1101/2022.01.19.476497}
}